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Abstract
Background: Literature highlighted the importance of timely access and ongoing care provided at primary care
settings in reducing hospitalisation and health care resource uses. However, the effect of timely access to primary
care has not been fully captured in most of the current continuity of care indices. This study aimed to develop a
time-duration measure of continuity of primary care (“cover index”) capturing the proportion of time an individual
is under the potentially protective effect of primary health care contacts.
Methods: An observational study was conducted on 36,667 individuals aged 45 years or older with diabetes
mellitus extracted from Western Australian linked administrative data. Threshold effect models were used to
determine the maximum time interval between general practitioner (GP) visits that afforded a protective effect
against avoidable hospitalisation across complication cohorts. The optimal maximum time interval was used to
compute a cover index for each individual. The cover was evaluated using descriptive statistics stratified by
population socio-demographic characteristics.
Results: The optimal maximum time between GP visits was 9–13 months for people with diabetes with no
complication, 5–11 months for people with diabetes with 1–2 complications, and 4–9 months for people with
diabetes with 3+ complications. The cover index was lowest among those aged 75+ years, males, Indigenous
people, socio-economically disadvantaged and those in very remote areas.
Conclusions: This study developed a new measure of continuity of primary care that adds a time parameter to
capturing longitudinal continuity. Cover has the potential to better capture underuse of primary care and will
significantly contribute to the sparsely available methods for analysis of linked administrative data in evaluating
continuity of care for people with chronic conditions.
Keywords: Cover index, Continuity of care, Optimal time interval, Diabetes mellitus, Primary care, Potentially
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Background
Given current pressures experienced by most health sys-
tems improvements in care delivery are needed to make
the system more effective, efficient and sustainable. Over
recent years the focus in many countries has been the
enhancement of primary health care to reduce poten-
tially preventable hospitalisations (PPH) which are often
costly and undesirable for patients [52]. The rationale
behind this is that timely utilisation and effective treat-
ment in primary health care (PHC) settings for people
with chronic conditions could afford a protective effect
in preventing complications and adverse health events
[10, 47]. For common chronic conditions such as dia-
betes, heart failure and asthma, a shift in focus from
acute to primary care has the potential to delay or even
prevent the onset of complications and reduce PPH.
This theory surrounding ‘ambulatory care sensitive con-
dition’ has been the driver of many policies aimed at in-
creasing long-term ongoing, rather than sporadic or
episodic, contact with a General Practitioner (GP).
The Australian government has set a focus on
strengthening the PHC system to address inequities and
future challenges of chronic diseases [15]. One of the
ways this is being undertaken is by providing financial
incentives for aspects of PHC and general practitioner
(GP) behaviour, such as the introduction of Primary
Health Networks, Integrated Care Models, Service/Prac-
tice Incentive Payments, Health Care Homes, Chronic
Disease Management Medicare Benefits Scheme items
and Home Medication Reviews [39]. Although GPs act
as the gatekeeper of the health care system in Australia,
it is not required that individuals register with a single
practitioner or general practice. People are free to visit
any GP they wish and can visit multiple GPs and general
practices simultaneously. The role of GPs has been
emphasised that GPs are the only physicians appropriate
for taking the leading roles in the primary health care
team and coordinating with other health care profes-
sionals into providing the best patient centred care in-
cluding diagnosis, treatment and management [5].
Continuity of care (COC) is an important component
of high-quality primary care as it is associated with in-
creased patient satisfaction, quality of life and health
outcomes [29, 42, 45, 49]. New models of care often rely
on the theoretical link between COC and better health
outcomes. A well-known conceptual framework of con-
tinuity of care proposed that continuity of care is a com-
bination of three essential components: interpersonal
continuity, management continuity and informational
continuity [29, 32]. Interpersonal continuity is defined as
an ongoing relationship between a patient and the same
provider where the relationship between patients and
providers are strengthen through mutual familiarity and
personal trust [32]. Informational continuity is a link
between providers to share comprehensive information
about patients’ history of care and circumstances that
helps to reduce duplicative and wasteful resources [32].
Management continuity is a collaboration between pro-
viders to ensure services delivered regularly and comple-
mentary and especially important in chronic and
complex conditions which require management from
multiple providers [32]. A sufficient continuity of care
requires a presence of both care of an individual and
proper management of care linked over time (Barker,
Steventon, and Deeny 2017; [32]).
Although interpersonal continuity of care can be easily
measured and widely used in literature [6, 7, 12, 18, 42],
it is becoming more difficult to sustain due to the chan-
ging size of practices over time and to the recent evolu-
tion of large multi-partner (or corporate) practices
rather than the solo-practice model common in previous
decades (Gulliford, Naithani, and Morgan 2006; [32]). In
the current context of a high burden of complex and
multiple chronic conditions, health care for people with
complex needs is now extended to a wide range of skills
and settings to better manage chronic conditions [28, 29].
Thus, the view of continuity of care is concerned with
management continuity - the extent of health care pro-
vided over time in a coordinated manner with appropriate
response to patients’ needs [28]. While continuity of care
is a complex multi-dimensional concept, current measures
of continuity of care mostly reflect interpersonal continu-
ity of care [6, 7, 36, 38]. Development of measures which
can integrate management aspect of continuity would be
useful to support comprehensive evaluations on continuity
of care and optimising efficiency in management of
chronic disease.
Few recent studies have considered management as-
pect of continuity of care in term of regularity of visiting
GPs which captures the degree of regular contact with
PHC providers [19, 20, 26]. Studies reported that regu-
larity of contact is more important than the frequency of
contact for reducing number and costs of hospitalisa-
tions [55, 56]. Greater regularity of visits more likely in-
dicates care which is planned and proactive, while visits
on an irregular basis (even if frequent/numerous) likely
indicate care which is unplanned or reactive and thus
not indicative of good ongoing management [43].
Current evidence also shows that use of the Enhanced
Primary Care Medicare items increases regular PHC
contact in the following year [26, 55], suggesting that re-
gularity is suitable as a target for health policy interven-
tion [25, 26].
Our new time-duration concept extends on the con-
cept of regularity by adding a time component. This is
important as care can be regular if a patient sees their
GP once per year, but this might not be sufficient (i.e.
the time-duration may be too long between visits) to
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provide adequate management of the patient’s condition
and therefore some of the protective effects of regular care
may be lost. Although the concept of time duration between
services is relative new in health care services research, it
has been integrated in other research areas such as customer
relationship management [35, 40, 41, 46] and pharmaceut-
ical studies to capture medication persistence – a proportion
of time duration under adequate medication supply [9, 48].
Our new metric – the Cover Index is defined as the propor-
tion of days, within a fixed ascertainment period (preferably
1 year since this is the time period that current chronic dis-
ease management plans are based [50]) that a patient is con-
sidered under the ‘protective effect’ of their PHC contact
and at reduced risk of PPH. In contrast to drug utilisation
studies where medication protective effect is well defined, in
primary care, no data exist providing the duration over
which a GP visit has the potential to protect a patient from
an adverse event or complication of their chronic disease.
We hypothesise that interaction with a GP can protect a
patient from experiencing a diabetes-related potentially pre-
ventable hospitalisation and that this protective effect can be
maintained if GP interactions fall within a particular max-
imum time interval (i.e. do not exceed this time) named the
“optimal maximum time interval”. Our study aimed to de-
velop a methodology for determining “cover” of primary care
using individual-level linked administrative data by (i) esti-
mating the optimal maximum time interval over which pri-
mary care affords an increased protection from PPH using
threshold effects models; and (ii) using the derived optimal
time period to operationalise “cover” at the individual level.
Methods
Time-duration index of continuity of primary care (cover)
development
The proposed time-duration index, which we call “Cover”,
is defined as the proportion of time that an individual is
under the potentially protective effect of PHC (via contact
with their GP) over a pre-specified ascertainment period.
Construction of the index relies on first determining a
period of time between GP visits that a patient with a
stated set of socio-demographic and clinical characteristics
has a reduced probability of PPH. We term this the ‘opti-
mal maximum time interval’. Once this optimal time
period has been determined cover can be calculated as
shown in Fig. 1. Briefly, the actual time interval (in days)
between each GP attendance within the ascertainment
period is first determined. This time is then compartmen-
talised into within and outside of the pre-defined optimal
maximum time interval for persons with pre-defined char-
acteristics in that year. The number of days within the op-
timal maximum time interval (i.e. days covered) are then
aggregated over an ascertainment period for each individ-
ual in the complication cohort and the proportion of the
total number of days eligible for cover over the ascertain-
ment period calculated. This provides the cover index,
which has a value between 0 and 1, for each individual in
each year in our scenario (or some other time period
chosen based on specific clinically or policy based ration-
ale). A higher score reflects a greater proportion of time
‘covered’. Although methods used to calculate the cover
score were demonstrated in complication cohorts of
people with diabetes, the methods are applicable to other
ambulatory care sensitive conditions.
Estimation of the optimal time interval for GP services in
people living with diabetes
Data sources
Western Australia (WA) whole-of-population adminis-
trative health data linked at the individual level for
adults aged 18 years or older enrolled to vote in WA at
any time between 1 July 1990 and 30 June 2004 were
used for this study. The data included four datasets: WA
Fig. 1 Calculation of cover index
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Hospital Morbidity Data System (HMDS); Medicare
Benefits Scheme (MBS) claim records; WA Electoral
Roll (ER) records and WA mortality records. The
HMDS provided information on diagnosis, date of ad-
mission and date of discharge from all WA hospitals.
The MBS provided information on services provided
outside the hospital (for example GP services) and in-
cluded the date of service and type of medical service.
The ER provided information on dates of migration in
and out of WA or changes in a residential address while
living in WA. Mortality records provided date and cause
of death. WA data were linked and extracted via the
WA Data Linkage System (WADLS)[33] and MBS data
by the Commonwealth Department of Health and Age-
ing using a linkage key provided by the WADLS.
Study population
The study population consisted of people living with dia-
betes aged 45 years and older in WA for the years 1998/
99 to 2003/04. Individuals with diabetes mellitus were
determined using the International Classification of Dis-
ease, 9th edition-clinical modification (ICD-9-CM) codes
in HMDS records and MBS claims indicative of the
presence of diabetes using all the available data and has
been described previously [31]. Three diabetes complica-
tion cohorts were constructed for this study depending on
level of disease at each observed year: no diabetes compli-
cations, 1–2 complications and 3+ complications. Compli-
cation severity level was assessed using the complication
severity index suggested by Young et al. [57] and stratified
into three groups as outlined previously [31].
All individuals were observed annually from the baseline
year to 30 June 2004, or last year living in WA or death
with the data constructed as a panel (with years nested
within a person). Only individuals who were alive and resi-
dent in WA for at least two consecutive years were in-
cluded in the study. Individuals could move to a higher
complication cohort if their complication status changed as
ascertained at the end of each observed year. Within each
complication cohort, we measured individual characteristics
including GP utilisation, hospitalisations, complications, co-
morbidities and socio-demographic characteristics in each
observed year, and GP utilisation and hospitalisations in the
following year. A similar design has been applied in other
studies [13, 31].
Ethical approval was provided by The University of
Western Australia and Curtin University Human Re-
search Ethics Committees.
Dependent variable
The number of diabetes-related potentially preventable
hospitalisations during each follow-up year was the main
outcome of the study. Diabetes-related hospitalisations
were identified using ICD-9-CM and ICD-10-AM codes
suggested by the National Health Performance Frame-
work [1] and hospitalisations where diabetes was identi-
fied as a significant risk factor by Davis et al. [14].
Independent variables
GP utilisation including frequency of GP services and
the time interval between GP services were focal mea-
sures in this study. For each individual, the date of GP
services within a financial year was identified in MBS
data. The time between GP visits was determined by
number of days: (1) between GP visits within a financial
year and; (2) between the date of first GP visit of a finan-
cial year and the date of the last GP visit in the previous
financial year(s) looking back up to 3 financial years. In
the case where a hospitalisation was observed, time was
counted either to the first GP visit post-hospitalisation
provided that the GP visit was within 14 days of dis-
charge or from day 14 after hospital discharge date and
the next GP visit [37]. The 14 day rule was applied based
on a large scale study which suggests that timely
follow-up within 14 days of discharge may be considered
to reduce the risk of readmission for patient with mul-
tiple complex chronic conditions such as diabetes, heart
disease and chronic obstructive pulmonary disease [37]
and that time in excess of that would be deemed “out of
cover”. The time intervals within a financial year were
used to calculate the mean time interval for a GP visit,
the variance of the time intervals and maximum time
interval to a GP visit in months (or part thereof ) of the
financial year for each individual.
As mean time interval reflects central tendency of time
intervals between services, two individuals can have the
same mean time interval but their maximum time inter-
val may be entirely different. In addition, the maximum
time interval is more likely to capture the period of time
that people were not covered by any protective effect of
GP service contact than mean time interval. Thus, the
maximum time interval to a GP visit in the following
year was used as the main predictor of the number of
hospitalisation in all analyses while mean time interval,
frequency and regularity in the same year as well as
mean time interval and regularity in the last year com-
prised covariates.
The variance of the time intervals was used to calcu-
late the annual regularity of GP visits as [1/(1 + vari-
ance)] for each individual, described in detail elsewhere
[19, 20, 26]. This regularity score was then converted
into quintiles for each complication cohort. The fre-
quency of GP usage was defined as a total number of
GP visits within a financial year excluding those GP
visits occurring within 14 days of the previous GP visit.
This exclusion was to minimise over counting GP ser-
vice utilisation as the visits within 14 days were thought
by our expert primary care clinicians more likely to be
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associated with the existing episode of care rather than
being indicative of a new episode (e.g. returning for the
results of tests), recommended in the literature [17].
A number of individual socio-demographic and clinical
characteristics were also measured. Demographic charac-
teristics included were age groups (45–59 years, 60–74
years and ≥ 75 years), gender, and Indigenous status.
Socio-economic status was assessed annually using quin-
tiles of the Census specific Socio-Economic Indexes for
Areas (SEIFA) Index of Relative Socioeconomic Disadvan-
tage [4]. Service accessibility was measured annually clas-
sified as very remote, remote, moderate, accessible and
highly accessible [3]. The number of comorbidities was
summed using MACSS index [34], excluding conditions
classified as complications of diabetes. Duration of dia-
betes was calculated in years from the first identification
in WA linked data. Other use of health services was
accounted for by capturing the number of specialist visits
and the number of non-diabetes related hospitalisations in
each financial year.
Average cost per hospitalisation was calculated and
used to describe the characteristics of each complication
cohort but not used as a controlling variable in regres-
sion models. Costs were assigned using Australian Re-
fined Diagnostic Related Group costs from the National
Hospital Cost Data collection and National Efficient
Price of the Independent Hospital Pricing Authority
[16]. All costs were adjusted to 2014 Australian dollar
using the Consumer Price Index.
Statistical analyses
The data for each complication cohort were constructed
as a panel data structure with multiple measures for
each individual, such that response and control variables
could vary over the study period. Panel data were com-
plex and unbalanced as individuals could move in and
out of WA, die or move to higher complication level co-
hort during the study period. Characteristics of the
population were described for each complication cohort
at the time entering to the cohort.
To estimate the optimal maximum time interval we
employed threshold effects model proposed by (Gannon,
Harris, and Harris 2014) to examine how the relation-
ship between GP service and diabetes-related potentially
preventable hospitalisation varies with the length of the
time interval (the maximum time interval) between GP
services. The model proceeded by searching for sample
heterogeneity in the response of diabetes-related poten-
tially preventable hospitalisation to variation in the time
interval between GP services across populations in each
complication cohort. The information criteria approach
including Bayes Information Criterion (BIC) and Akaike
Information Criterion (AIC) statistics was used to select
the optimal model. The selected model was used to
identify a number of subpopulations defined in terms of
length of the time interval between GP services. The op-
timal model was used to suggest the maximum optimal
time interval between GP services where the number of
diabetes-related potentially preventable hospitalisations
was minimal. The threshold effects model evaluates all
subpopulations simultaneously rather than sequentially
and therefore extends towards a non-linear model [22,
23, 27] that allows more flexibility in examining the rela-
tionship between GP service and the risk of
diabetes-related potentially preventable hospitalisation.
This approach has been applied in previous studies [24,
31].
The threshold effects model in our study was an ex-
tension of the random effects negative binomial model
for panel data which accounts for time-variant factors
and unbalance in the data structure. The general form of
the model for individual i in year t presented as follows:
HOSPit ¼
XM
m¼1
γmRm;i  ðTInti;t
 GPsvci;t GPsvci;t ¼ 1TInti;t ≤18
 
þ β1 D1 ¼ 1 jGPsvci;t ¼ 0
 
þ β2 D2 ¼ 1j TInti;t > 18
   Tinti;t
þ β1Xi;t þ β2xi;t þ αi þ HOSPt0 þ Ui;t
þ β0
; i ¼ 1; 2…N ; t ¼ 1; 2…;T
The equation is the hypothesised differential effect of
GP services (GPsvci, t) on diabetes-related PPH (HOSPit)
with respect to an individual’s position with regard to
the maximum time interval (TInti, t ) to the next GP ser-
vice. The threshold model allows the coefficient γm on
GP service to vary according to the time interval to a
GP service (in month) indicated by subpopulation indi-
cators: Rm, i = 1 if {τm − 1 < Tinti, t ≤ τm}, and 0 other-
wise, where m is the number of subpopulation and τ is
the threshold parameters. The number of subpopulation
m (1, 2, 3 … M) and the threshold parameters τ was es-
timated from the data. The model splits the data into M
subpopulations. The M = 1 setting gives the constant co-
efficient as a standard negative binomial model.
The threshold variable Ri only took values from 1 to
18 for two reasons: 1) 99% of the population in each
complication cohort had a maximum time interval to a
GP service ≤18months, the sample size for the time
interval > 18months was relatively small (about 90 or
less records for each time interval); 2) it was more com-
putationally feasible as we could reduce the searching
time. However, we still included the cases with the time
interval > 18months as a controlling variable (D2) with
value of 1 if the maximum time interval > 18 months,
and 0 otherwise.
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The threshold effects model included a dummy vari-
able (D1) for any observation with no GP service in a fi-
nancial year to control for, rather than excluding, the
observation. The model also included demographic and
clinical characteristics in the observed years and GP util-
isation in both observed and follow-up years in the nota-
tion Xi, t to control for any confounding. Endogeneity
due to a correlation between the error term and the
maximum time interval has been minimized by adding
Mundlak variables xi,t, which are group means of
time-varied variables including frequency of GP visits,
regularity of GP visits and comorbidities. The group
mean of time-varied variables relax the assumption of
the random-effects estimator that unobserved factors
were independent with the observed factors [11, 44]. In
addition, the model also included initial conditions (his-
tory of hospitalisation at the baseline year, and GP utili-
sations in the previous years) to adjust for effects of
unobserved heterogeneity [54].
All competing models were compared using their BIC
and AIC statistics. The preferred model was the one
which minimised the appropriate information criteria
(AIC and BIC) [23]. Within each diabetes complication
cohort, the preferred model indicated the maximum
time interval to a GP service which had minimal risk of
diabetes-related potentially preventable hospitalisations
and suggested the maximum optimal time interval to a
GP service corresponding to each diabetes complication
cohort that was subsequently used to operationalise the
cover index.
All analyses were conducted using STATA for Window
version SE14.1.
Operationalizing the cover index in the diabetes cohort
In this demonstration, the cover index was calculated
for each financial year (July 1st to June 30th) for the
studied period of 1998 to 2004, date of death or date of
leaving WA which ever came first. The year of death
was excluded from the analysis. Thus, part-years were
not considered in the Cover Index calculation. For each
financial year, the ascertainment days were the total
number of days that people were living in the commu-
nity (i.e. not in hospital).
Days out of GP cover (DOC) were calculated by sub-
traction of the pre-defined optimal maximum time inter-
val (updated according to diabetes severity level) from
the actual time interval between a GP service and the
next health care service (either GP or hospital admis-
sion). Thus, by definition DOC values were positive. Any
time interval that was shorter than the optimal max-
imum time interval was deemed as “under cover”, thus,
DOC was counted as zero.
The cover index = [∑ascertainment days - ∑DOC] /
∑ascertainment days] was calculated for each individual
annually. As the optimal maximum time interval was
identified as a range of values from the threshold effects
model, the cover index was calculated with low, middle
and upper values bounds corresponding to low, middle
and upper values of the optimal maximum time interval
identified for each complication cohort (Fig. 1).
Values of cover were reported by socio-demographic
characteristics of the cohort to explore the range of
scores and serve to evaluate the face validity of the cover
index in capturing vulnerable groups which traditionally
have poor continuity of primary care.
Results
Characteristics of diabetes complication cohorts at the
time entering the cohort
A total of 36,667 individuals aged 45 years or older were
classified as living with diabetes in WA in this study.
Since individuals could change complication cohorts (i.e.
move to a higher complication group) throughout the
study the total number of individuals shown in Table 1
reflects the number of individuals who were classified in
that particular complication cohort at any time and is
thus larger than the total number of individuals in the
study. The complication cohorts are not mutually exclu-
sive over the entire study period but are mutually exclu-
sive within individual years (i.e. an individual cannot be
in more than one complication cohort in the same fi-
nancial year). During the studied period, 8968 individ-
uals changed complication cohorts.
Characteristics of the individuals at the time of entry
into each complication cohort is presented in Table 1.
Compare with individuals in the cohort with no compli-
cation, individuals in cohorts with higher complications
were older (38.7% of those in three complication cohort
and 25.8% of those in one or two complication cohort
aged 75 years or older vs. 10.8% among those with no
complication); had a higher number of comorbidities
(average of 8.3 and 5.7 vs. 3.0 comorbidities, respect-
ively); a longer duration of diabetes (9.2 years and 7.2
years vs. 5.4 years, respectively), a higher number of hos-
pitalisations (1.8 and 0.53 hospitalisation per year vs.
0.03 hospitalisation per year, respectively) and higher
average cost per hospitalisation (AU$ 7756.2 and AU$
5637.4 per hospitalisation vs. AU$ 3993.2). However,
other characteristics such as gender, socio-economic sta-
tus and accessibility to services and GP usage did not
vary between complication cohorts.
Estimation of the optimal maximum time intervals for
each diabetes complication cohort
Table 2 shows the results of the threshold effects model
which presents how the relationship between GP service
and the risk of diabetes-related PPH varies across the
length of the maximum time interval between GP
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Table 1 Characteristics of studied population at the time entering each complication cohort
Characteristics No complication One or two complications Three complications or more
(N, (%)) (N, (%)) (N, (%))
N 20,039 14,866 10,730
Age group (years)
45–59 9223 (46.0) 3849 (25.9) 1869 (17.4)
60–74 8650 (43.2) 7178 (48.3) 4708 (43.9)
≥ 75 2166 (10.8) 3839 (25.8) 4153 (38.7)
Gender
Female 9741 (48.6) 7263 (48.8) 5000 (46.6)
Male 10,298 (51.4) 7603 (51.1) 5730 (53.4)
Indigenous status
No 17,911 (95.9) 13,937(93.7) 9880 (92.1)
Yes 771 (4.1) 929 (6.2) 850 (7.9)
SEIFA
Highest Disadvantage 3951 (19.8) 3232 (21.9) 2445 (22.9)
High disadvantaged 5540 (27.8) 4302(29.1) 3128 (29.3)
Moderate disadvantage 2792 (14.0) 2126 (14.4 1496 (14.0)
Less disadvantage 3205 (16.1) 2226 (15.1) 1582 (14.8)
Least disadvantage 4412 (22.2) 2876 (19.5) 2005 (18.8)
Accessibility
Very remote 553 (2.8) 606 (4.1) 525 (4.9)
Remote 359 (1.8) 277 (2.0) 186 (1.7)
Moderate 945 (4.7) 772 (5.2) 603 (5.6)
Accessible 1039 (5.2) 843 (5.7) 627 (5.9)
Highly accessible 17,004 (85.4) 12,265 (83.0) 8716 (81.9)
Number of comorbidity
Mean (SD) 3.0 (2.9) 5.7 (3.1) 8.3 (3.1)
Duration of diabetes (years)
Mean (SD); 5.4 (3.8) 7.2 (4.2) 9.2 (4.7)
Regularity quantiles
No regularity 4765 (23.8) 3150 (21.2) 2382 (22.2)
Quantile 1 3833 (19.1) 2776 (18.7) 2082 (19.4)
Quantile 2 3850 (19.2) 2873(19.3) 2070 (19.3)
Quantile 3 3772 (18.8) 2975 (20.0) 2116 (19.7)
Quantile 4 3819 (19.0) 3092 (20.8) 2080 (19.4)
Average time to a GP visit (months)
Mean (SD)
3.6 (3.2) 2.8 (2.5) 2.4 (2.1)
Frequency of GP visits
Mean (SD)
4.7 (2.8) 5.1 (3.0) 5.2 (3.2)
Number of specialist visits
Mean (SD)
2.4 (4.1) 4.5 (6.5) 5.5 (9.2)
Number of non-diabetes related hospitalization 0.35 (1.57) 0.72 (2.3) 1.04 (1.85)
Number of diabetes related hospitalization 0.03 (1.06) 0.53 (1.7) 1.8 (10.8)
Average costs per diabetes related hospitalizations (2014 A$) (Mean (SD)) 4381.2 (3828.7) 5185.5 (5492.7) 8192.7 (8992.6)
Min-Max 800.8–38,842.4 748.8–128,552.6 598.2–144,061.3
Average costs per non-diabetes related hospitalizations (2014 A$) (Mean (SD)) 3993.3 (4132.2) 5637.4 (7964.4) 7756.2 (12,172.2)
Min-Max 393.4–61,680.1 393.4–142,694.4 662.2–227,080.1
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services by complication cohort. Based on both BIC and
AIC, the preferred models indicated a non-linear rela-
tionship between maximum time interval between GP
visits and the number of hospitalisations with five sub-
populations in both no complication cohort and one or
two complication cohort and four subpopulations in
three or more complication cohort (Table 2). Overall,
the expected number of diabetes related PPH was ob-
served lowest in a maximum time interval between GP
visits of 9 months to 13months for diabetes with no
complication; 5 months to 11 months for diabetes with
one or two complications; and 4 months to 9 months for
diabetes with three or more complications. For no com-
plication cohort, the average number of predicted dia-
betes related potentially preventable hospitalisation
within the optimal maximum time interval was 0.044
(95%CI, 0.043–0.045) admissions while the number was
significantly higher among the sub-optimal time inter-
vals (0.127 (95%CI, 0.126–0.128)). For one or two com-
plication cohort, the average number of predicted
diabetes related potentially preventable hospitalisation
within the optimal maximum time interval was 0.159
(95%CI, 0.158–0.160) admissions while the number of hos-
pitalisation was significantly higher among sub-optimal
time interval (0.314 (95%CI, 0.311–0.316)). For three or
more complication cohort, the predicted number of dia-
betes related potential preventable hospitalisations within
the optimal maximum time interval was 0.589 (95%CI,
0.583–0.595) admissions while the number of hospitalisa-
tions was significantly higher among the sub-optimal time
interval (1.15, 95%CI 1.14–1.16). The change in the number
of predicted diabetes-related potentially preventable hospi-
talisations across the maximum time interval between GP
visits using spline function is also presented in Fig. 2.
Cover index and its distributions
Table 3 shows the annual average cover index score
overall for the whole studied population and by
socio-demographic characteristics. Overall, the average
cover score was 0.85 (upper bound) (95%CI 0.80 to 0.85)
indicating that on average, in this cohort, 85% of the
year people with diabetes were under the potentially
protective effect of PHC via contact with their GP. How-
ever, only 83% of the time period was covered if the
lower boundary of the optimal maximum time interval
was considered rising to 84% of the time interval cov-
ered if the middle bound of the optimal maximum time
interval was considered. The cover index score changed
by socio-demographic characteristics. The lowest aver-
age cover index scores across low, middle and upper
bounds was observed among those aged 75 years or
older (0.77–0.78 - 0.79, respectively), males (0.80–0.82 -
0.83, respectively), indigenous (0.60–0.63 - 0.64, respect-
ively), having highest disadvantage (0.81–0.82 - 0.83,
respectively) and living in very remote areas (0.48–0.51 -
0.52, respectively).
Discussion
Our study aimed to develop and operationalise the cover
index, a novel measurement of continuity of primary
care that represents an improvement in existing mea-
surements of regularity of primary care through ac-
counting for a time-limited protective effect achieved
from interaction with a GP. This study presented an em-
pirical approach to estimate the optimal time period for
GP cover in a diabetes patient population in order to
demonstrate its operationalisation, however, we suggest
that the cover index could be flexibly operationalised
with a range of a priori optimal time periods, such as
those based on expert opinion or clinical guidelines, if
applicable, to aid in both the development and evaluation
of policies incentivizing provider-patient interactions. Dif-
ferences in the cover index score operationalised in this
way could be used as to evaluate the impact of such opin-
ion, guidelines or policy on potentially preventable hospi-
talisations. The tremendous growth in the availability and
range of whole-of-population administrative health data-
sets provide opportunities to measure the performance of
health systems and evaluate the impact of health policy.
However, currently available metrics are limited in their
sophistication regarding the domains within utilisation
they capture. The cover metric would significantly con-
tribute to the advancement of available methods for the
analysis of these data.
In these data, the threshold model indicated the opti-
mal maximum time interval of 9–13months for diabetes
without complication, 5–11 months for one or two com-
plications and 4–9 months for three or more complica-
tion where the risk of hospitalisation was minimised.
This finding is in line with the recommendation in pri-
mary care guidelines for diabetes [2, 51] which suggest
people with diabetes should receive primary care at
regular intervals of 3–12 months depending on the com-
plexity of individual needs. In addition, our findings are
consistent with growing evidence that optimised primary
care use may improve health outcomes and reduce re-
sources used [30, 58]. However, current evidence does
not clearly indicate specific time intervals for different
disease severity levels, which may limit the ability to ef-
fectively measure primary care performance and utilisa-
tion. In addition to facilitating the operationalisation of
cover our findings provide an important insight into pri-
mary care needs of people with diabetes corresponding
to their severity level that may provide evidence for im-
provement of primary care performance.
Recent studies show various approaches such as
counting a number of GP services in the short term or
long term prior hospitalisation [53] or visualizing the
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density of GP services [21] to examine utilisation of GP
services. In countries where GPs are the gatekeepers to ac-
cess for most medical services, using these approaches
may not capture underutilisation of GP services. Our
study suggests using the maximum time interval between
health care services in examining the relationship with the
risk of hospitalisation since the maximum time interval
drives attention towards the “long overdue period” likely
to reflect discontinuity of GP care and lost opportunities
for early treatment in the primary care setting.
Results of the variation in the average cover score
show disparities in GP cover that are associated with
socio-economic disadvantage, even though the results
are only exploratory. The results are consistent with the
literature showing poor access to primary care services
among people from the low socio-economic background,
Indigenous, and living in remote areas [8] and thus pro-
vide some face validity that the cover score performs in
the way expected. The results also provide a quantifica-
tion of the disparities in GP cover that is important
Fig. 2 Changes in number of hospitalisations across maximum time interval between GP visits by complication cohort
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information to target health care resources and provide
a tool to accurately quantify the improvement in primary
care resulting from interventions. Given the high burden
of hospitalisation, improvement in GP cover would offer
a cost-effective opportunity to reduce the costs of hospi-
talisation, especially among those with multiple compli-
cations. While not explored in this paper, in addition to
capturing periods that are not covered, the metric could
also be adapted to capture periods of “over cover” and
thus be used to measure over as well as under servicing.
Strengths and limitation of the study
The major strength of our study was using a threshold
effects model, an advanced and flexible approach to
comprehensively estimate the optimal time interval for a
GP visit. A further strength of this study is the large
population and comprehensive range of linked databases
used in the empirical analysis that allowed us to measure
and control any changes in both outcomes and expo-
sures over the studied period.
The cover metric developed in this paper does not in-
corporate the number of GPs or GP practices visited.
Since the purpose of the metric is to determine the in-
fluence of the time between visits adjusting for other di-
mensions of continuity (e.g. via the usual provider index,
the frequency of visits and the number of practices vis-
ited) in models would be superior to incorporating these
dimensions of continuity in the metric. Therefore, inclu-
sive measure of time duration in the design of the Cover
Index is a strength, since using the cover metric with
separate adjustment for other dimensions of continuity
allows the impact of the time duration component to be
separated from other components. This is more valuable
to practitioners and policy makers than a metric that re-
ports a combined impact. Interaction terms could be
used for evaluating various combinations of dimensions
if required.
Our study has some limitations to consider when inter-
preting the results. The empirical analyses were conducted
using data from 1990 to 2004, hence it cannot provide
Table 3 Average yearly cover score across maximal optimal time interval boundary over the studied period
Characteristics Low bound cover Middle bound cover Upper bound cover
mean 95% CI mean 95% CI mean 95% CI
Overall
Mean 0.83 (0.83; 0.83) 0.84 (0.84; 0.85) 0.85 (0.80; 0.85)
Median (IQR) 0.98 (0.81; 1.00) 1.00 (0.86; 1.00) 1.00 (0.87; 1.00)
Age group (years)
45–59 0.82 (0.81; 0.82) 0.84 (0.83; 0.84) 0.85 (0.84; 0.85)
60–74 0.87 (0.87; 0.87) 0.88 (0.88; 0.89) 0.89 (0.89; 0.89)
≥ 75 0.77 (0.77; 0.77) 0.78 (0.78; 0.79) 0.79 (0.78; 0.79)
Gender
Female 0.86 (0.86; 0.86) 0.87 (0.87; 0.87) 0.88 (0.88; 0.88)
Male 0.80 (0.80; 0.80) 0.82 (0.82; 0.82) 0.83 (0.83; 0.83)
Indigenous status
No 0.84 (0.84; 0.84) 0.86 (0.86; 0.86) 0.86 (0.86; 0.86)
Yes 0.60 (0.59; 0.61) 0.63 (0.62; 0.64) 0.64 (0.63; 0.65)
SEIFA
Highest Disadvantage 0.81 (0.80; 0.81) 0.82 (0.82; 0.83) 0.83 (0.83; 0.83)
High disadvantaged 0.83 (0.83;0.84) 0.85 (0.85; 0.85) 0.86 (0.85; 0.86)
Moderate disadvantage 0.83 (0.83; 0.84) 0.85 (0.85; 0.85) 0.86 (0.85; 0.86)
Less disadvantage 0.84 (0.84; 0.84) 0.86 (0.85; 0.86) 0.86 (0.86; 0.87)
Least disadvantage 0.84 (0.84; 0.84) 0.86 (0.85; 0.86) 0.86 (0.86; 0.87)
Accessibility
Very remote 0.48 (0.47; 0.49) 0.51 (0.50; 0.52) 0.52 (0.51; 0.53)
Remote 0.74 (0.73; 0.76) 0.77 (0.76; 0.78) 0.78 (0.77; 0.79)
Moderate 0.79 (0.79; 0.80) 0.82 (0.81; 0.82) 0.82 (0.82; 0.83)
Accessible 0.81 (0.81; 0.82) 0.83 (0.83; 0.84) 0.84 (0.84; 0.85)
Highly accessible 0.85 (0.85; 0.85) 0.86 (0.86; 0.87) 0.87 (0.87; 0.87)
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evidence regarding current utilisation of GP services. How-
ever, for the purposes of this paper, which sought to de-
velop and operationalise the cover metric, the lack of
contemporaneous data is unimportant. The cover metric
could have been developed solely using synthetic data; how-
ever the use of these historical data is a strength because
they allowed us to develop the metric using real world rela-
tionships between GP visits and other covariates and also
afforded us the opportunity undertake face validity of the
metric during the development stage. In addition, the use
of these historical data could be considered a strength be-
cause this particular time period incorporates a period in
Australia with little intervention aimed at increasing
provision of primary care for people with chronic condi-
tions. Thus, the data in this period could, with appropriate
control of confounding factors, provide the baseline needed
to identify the incremental impact of policies aimed at sup-
porting continuity of primary care, via changes in the cover
score and associated impact on PPHs.
Administrative data are not collected for research pur-
poses, hence, they do not include some details about se-
verity of disease. Our data also did not have information
about whether individuals visited the same or different
GPs which may have improved the threshold modelling of
our estimation of the maximum optimal time period. As
the same provider is a potential factor for a holistic ap-
proach to continuity of care, future work may wish to ex-
pend on the current metric with inclusion of such data.
The empirical results were limited to those who were clin-
ically diagnosed with diabetes and incur health care re-
source utilisation through hospitals or Medicare claims
that may affect generalisation of the maximal optimal time
period estimated. Although the covered time interval
found in our study relates only to diabetes at particular se-
verity levels, the cover metric has application to other am-
bulatory care sensitive chronic conditions.
Conclusions
Our study adds to the current literature by developing
and operationalizing a new approach to measuring con-
tinuity of primary care which incorporates time-duration
protective effects of primary care. This study used novel
threshold modelling to determine the impact of maximum
duration between GP services on preventable hospitalisa-
tion and used the estimated value to operationalise cover.
However, the operationalisation of cover is flexible and al-
lows for use of a priori time intervals, which makes it ideal
to evaluate clinical guidelines and policies that recom-
mend specified durations between GP visits.
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